IPHYF
Innate Pharma SA
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 5/19/2026 | View on SEC |
| 6-K | 5/13/2026 | View on SEC |
| 6-K | 5/12/2026 | View on SEC |
| 6-K | 5/6/2026 | View on SEC |
| 6-K | 4/23/2026 | View on SEC |
| 6-K | 4/17/2026 | View on SEC |
| 6-K | 4/13/2026 | View on SEC |
| 6-K | 4/13/2026 | View on SEC |
| SCHEDULE 13G/A | 4/10/2026 | View on SEC |
| 6-K | 4/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IPHYF |
| Company Name | Innate Pharma SA |
| CIK | 1598599 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | I0 |
| Phone | 33430303030 |